These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 2951609

  • 1. D-1 dopamine receptors labelled with 3H-SCH 23390: decrease in the striatum of aged rats.
    Giorgi O, Calderini G, Toffano G, Biggio G.
    Neurobiol Aging; 1987; 8(1):51-4. PubMed ID: 2951609
    [Abstract] [Full Text] [Related]

  • 2. Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striatum.
    Giorgi O, De Montis G, Porceddu ML, Mele S, Calderini G, Toffano G, Biggio G.
    Brain Res; 1987 Oct; 432(2):283-90. PubMed ID: 2960426
    [Abstract] [Full Text] [Related]

  • 3. Differential effect of aging on 3H-SCH 23390 binding sites in the retina and in distinct areas of the rat brain.
    Giorgi O, Porceddu ML, Pepitoni S, Serra GP, Toffano G, Biggio G.
    J Neural Transm Gen Sect; 1990 Oct; 82(3):157-66. PubMed ID: 2248731
    [Abstract] [Full Text] [Related]

  • 4. Target size of dopamine D-1 receptors in rat corpus striatum estimated by binding of the benzazepine 3H-SCH 23390.
    Gredal O, Nielsen M, Hyttel J.
    Pharmacol Toxicol; 1987 Apr; 60(4):255-7. PubMed ID: 2954035
    [Abstract] [Full Text] [Related]

  • 5. Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue.
    Faedda G, Kula NS, Baldessarini RJ.
    Biochem Pharmacol; 1989 Feb 01; 38(3):473-80. PubMed ID: 2563653
    [Abstract] [Full Text] [Related]

  • 6. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH, Dvorkin B.
    Brain Res; 1986 Dec 01; 387(3):261-70. PubMed ID: 2950967
    [Abstract] [Full Text] [Related]

  • 7. Brain D1 dopamine receptor in alloxan-induced diabetes.
    Salković M, Lacković Z.
    Diabetes; 1992 Sep 01; 41(9):1119-21. PubMed ID: 1386820
    [Abstract] [Full Text] [Related]

  • 8. The renal dopaminergic system in ageing.
    Ricci A.
    J Auton Pharmacol; 1990 Sep 01; 10 Suppl 1():s19-24. PubMed ID: 2151517
    [Abstract] [Full Text] [Related]

  • 9. Binding of (+)PHNO and other D2-dopamine agonists to D1-dopamine receptors labelled by [3H]SCH 23390.
    Pettibone DJ, Totaro JA, Clineschmidt BV.
    J Neural Transm; 1987 Sep 01; 69(1-2):147-51. PubMed ID: 2953862
    [Abstract] [Full Text] [Related]

  • 10. Chronic estradiol treatment increases ovariectomized rat striatal D-1 dopamine receptors.
    Lévesque D, Di Paolo T.
    Life Sci; 1989 Sep 01; 45(19):1813-20. PubMed ID: 2531825
    [Abstract] [Full Text] [Related]

  • 11. Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SCH 23390.
    Savasta M, Dubois A, Scatton B.
    Brain Res; 1986 Jun 11; 375(2):291-301. PubMed ID: 2942221
    [Abstract] [Full Text] [Related]

  • 12. Characterization of binding of 3H-SCH 23390 to dopamine D-1 receptors. Correlation to other D-1 and D-2 measures and effect of selective lesions.
    Hyttel J, Arnt J.
    J Neural Transm; 1987 Jun 11; 68(3-4):171-89. PubMed ID: 2881976
    [Abstract] [Full Text] [Related]

  • 13. Loss of rat striatal dopamine receptors with ageing is selective for D-2 but not D-1 sites: association with increased non-specific binding of the D-1 ligand [3H]piflutixol.
    O'Boyle KM, Waddington JL.
    Eur J Pharmacol; 1984 Oct 01; 105(1-2):171-4. PubMed ID: 6149143
    [Abstract] [Full Text] [Related]

  • 14. Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo.
    Leslie CA, Bennett JP.
    Brain Res; 1987 Jul 07; 415(1):90-7. PubMed ID: 2957025
    [Abstract] [Full Text] [Related]

  • 15. [3H]SCH 23390 binding sites increase after chronic blockade of D-1 dopamine receptors.
    Porceddu ML, Ongini E, Biggio G.
    Eur J Pharmacol; 1985 Dec 03; 118(3):367-70. PubMed ID: 2935413
    [Abstract] [Full Text] [Related]

  • 16. Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.
    Billard W, Ruperto V, Crosby G, Iorio LC, Barnett A.
    Life Sci; 1984 Oct 29; 35(18):1885-93. PubMed ID: 6387355
    [Abstract] [Full Text] [Related]

  • 17. 6-Hydroxydopamine-induced degeneration of nigral dopamine neurons: differential effect on nigral and striatal D-1 dopamine receptors.
    Porceddu ML, Giorgi O, De Montis G, Mele S, Cocco L, Ongini E, Biggio G.
    Life Sci; 1987 Aug 10; 41(6):697-706. PubMed ID: 2956472
    [Abstract] [Full Text] [Related]

  • 18. Postnatal development of dopamine D1 and D2 receptor sites in rat striatum.
    Gelbard HA, Teicher MH, Faedda G, Baldessarini RJ.
    Brain Res Dev Brain Res; 1989 Sep 01; 49(1):123-30. PubMed ID: 2529061
    [Abstract] [Full Text] [Related]

  • 19. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
    Urwyler S, Markstein R.
    J Neurochem; 1986 Apr 01; 46(4):1058-67. PubMed ID: 2936868
    [Abstract] [Full Text] [Related]

  • 20. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat.
    Graham WC, Crossman AR, Woodruff GN.
    Brain Res; 1990 Apr 23; 514(1):93-102. PubMed ID: 2113410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.